Microvision, Inc. (MVIS) Stock Price & Analysis

Microvision, Inc. (MVIS) fell 6.94% to USD 0.36 as of June 10, 2026 at 05:06 UTC, according to Nexqual real-time market data.

MVIS last closed at USD 0.39; the session ranged USD 0.35–0.39 on volume of 14,160,430 shares. Market capitalization is $119.15M, with a 52-week range of USD 0.35–1.73 (NGM). Source: Nexqual, June 10, 2026 at 05:06 UTC.

Key Statistics (as of June 10, 2026 at 05:06 UTC)

PriceUSD 0.36
Change▼ 6.94% (down)
Previous CloseUSD 0.39
OpenUSD 0.39
Day RangeUSD 0.35 – 0.39
52-Week RangeUSD 0.35 – 1.73
Volume14,160,430 shares
Market Cap$119.15M
ExchangeNGM

Technical Analysis (MVIS)

Nexqual's technical model rates MVIS "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:06 UTC.

Overall SignalSELL
RSI (14)29.29 (oversold)
vs SMA50Below (USD 0.61)
MACD-0.06 (negative)

Analyst Ratings (MVIS)

Wall Street analysts rate MVIS "None", per Nexqual as of June 10, 2026 at 05:06 UTC.

Consensus RatingNone
Buy / Hold / Sell1 / 0 / 0

Earnings (MVIS)

Next Earnings Date2026-08-13

Recent Earnings History

QuarterActual vs Estimate
2025-09-30USD -0.05 vs est -0.06 ▲ beat
2025-06-30USD -0.06 vs est -0.07 ▲ beat
2025-03-31USD -0.11 vs est -0.07 ▼ miss

Source: Nexqual, June 10, 2026 at 05:06 UTC.

Financials & Fundamentals (MVIS)

Total Revenue$1.55M
Revenue Growth (YoY)+58.70%
Gross Margin+0.00%
Operating Margin-2213.16%
Profit Margin+0.00%
ROE-197.30%
Debt / Equity135.09
Current Ratio1.05
Total Cash$46.12M
Total Debt$53.42M
Free Cash Flow$-30.87M

Source: Nexqual, June 10, 2026 at 05:06 UTC.

Financial Health Score (MVIS)

Nexqual rates Microvision, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:06 UTC.

GrowthCritical — Revenue -74% YoY (annual), sharp decline
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetMixed — $46M cash vs $53M debt
Cash FlowWeak — FCF negative: -$31M, burning cash
EfficiencyCritical — ROE -197%, ROA -41.9%

Ownership (MVIS)

Insider Ownership+1.55%
Institutional Ownership+26.94%
Shares Outstanding331.62M
Float326.70M
Short % of Float+21.01%

Source: Nexqual, June 10, 2026 at 05:06 UTC.

Leadership (MVIS)

Microvision, Inc. is led by Glen W. DeVos (age 63), CEO & Director, per Nexqual as of June 10, 2026 at 05:06 UTC.

CEO & DirectorGlen W. DeVos (age 63)
Interim Chief Financial OfficerStephen Hrynewich (age 58)
Vice President of Product Engineering & OperationsFabio Laura

Major Backers & Investors (MVIS)

Notable institutional backers of Microvision, Inc. include Fidelity, Hudson Bay Capital Management Lp, UBS Group AG, according to Nexqual as of June 10, 2026 at 05:06 UTC.

Active Investors

InvestorStake
Fidelity1.32%
Hudson Bay Capital Management Lp0.9%
UBS Group AG0.74%
MCF Advisors LLC0.7%
Charles Schwab Investment Management, Inc.0.64%

Index Funds (Passive)

FundStake
Vanguard Group12.6%
BlackRock8.76%
State Street3.86%
Geode Capital2.1%
Northern Trust0.69%

Source: Nexqual, June 10, 2026 at 05:06 UTC.

From Microvision, Inc.'s Latest SEC 10-K Filing (filed 2026-03-04)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
OCGNOcugen, Inc.USD 1.24▼ 3.13%
BNGOBionano Genomics, Inc.USD 1.16▼ 0.85%
NNDMNano Dimension Ltd.USD 1.49▼ 4.49%
CLOVClover Health Investments, CorpUSD 4.29▲ 12.01%
SENSSenseonics Holdings, Inc.USD 7.43▲ 11.39%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:06 UTC. This page is informational and not investment advice.